EP2642999
Aðferðir til meðhöndlunar með því að nota valvísa Bcl-2 hindra
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
22.11.2011EP published:
28.9.2016EP application number:
11793928.0
EP translation filed:
23.11.2016Grant published:
15.12.2016EPO information:
European Patent Register
Max expiry date:
21.11.2031Expiry date:
21.11.2021
Title:
METHODS OF TREATMENT USING SELECTIVE BCL-2 INHIBITORS
Timeline
Today
22.11.2011EP application
28.9.2016EP Publication
23.11.2016Translation submitted
15.12.2016Registration published
21.11.2021Expires
Owner
Name:
AbbVie Ireland Unlimited CompanyAddress:
70 Sir John Rogerson's Quay, 2, Dublin, IE
Inventor
Name:
ELMORE, StevenAddress:
Northbrook, Illinois, US
Name:
SOUERS, AndrewAddress:
Evanston, Illinois, US
Name:
WANG, Li ChunAddress:
North Grafton, Massachusetts, US
Name:
GHAYUR, TariqAddress:
Holliston, Massachusetts, US
Name:
PERPER, Stuart J.Address:
Bellingham, Massachusetts, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
416689 PDate:
23.11.2010Country:
US
Classification
Categories:
A61K 31/496, A61P 37/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 10.11.2016
Expires: 21.11.2017
Payer: Örn Þór, slf.
Number: 7
Paid: 13.10.2017
Expires: 21.11.2018
Payer: Örn Þór, slf.
Number: 8
Paid: 11.10.2018
Expires: 21.11.2019
Payer: Örn Þór, slf.
Number: 9
Paid: 15.10.2019
Expires: 21.11.2020
Payer: Örn Þór, slf.
Number: 10
Paid: 13.10.2020
Expires: 21.11.2021
Payer: Örn Þór slf.